Biography

Rodica Busui, MD, PhD, is the Larry D. Soderquist Professor of Diabetes, and a recognized national and international leader in the field of diabetes and diabetes complications. She is the Vice Chair for Clinical & Health Outcomes Research in the Department of Internal Medicine, and Director of Clinical Research, Mentoring and Development of the Caswell Diabetes Institute at the University of Michigan. Her research interests involve chronic complications of diabetes, particularly diabetic peripheral and cardiovascular autonomic neuropathy, diabetic foot complications, diabetic kidney disease, the cardiovascular complications of diabetes, as well the design and conduct of traditional and pragmatic clinical trials in diabetes and diabetes complications. She has been PI and member of the Steering Committee in several landmark diabetes clinical trials funded by NIH or Pharma including: Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, Preventing Early Renal Loss in Type 1 Diabetes (PERL), Bypass Angioplasty Revascularization Diabetes 2 (BARI- 2D), Glycemia Reduction Approaches in Type 2 Diabetes-A Comparative Effectiveness Study (GRADE), REPLACE-BG, Wireless Interventions for Seniors With Diabetes Mellitus (WISDM), T1D Exchange, DEVOTE, or MOBILE. She designed and led several investigator-initiated studies funded by NIDDK and Pharma to unveil disease modifying agents for diabetic neuropathy and other chronic diabetes complications. Dr Busui is the corresponding principal investigator and member of the Steering Committee of the recently established NIDDK Diabetes Foot Consortium and one of the principal investigators of the JDRF Center of Excellence at the University of Michigan. Dr. Busui has published more than 250 peer-reviewed manuscripts and book chapters, and has mentored numerous early career faculty, fellows, postdoctoral fellows, residents, and students. She had received awards from the Fulbright Foundation, American Diabetes Association (ADA) and the University of Michigan. Dr Busui is the recipient of Doctor Honoris Causa degree from the University of Medicine and Pharmacy Victor Babes Timisoara. She has chaired the 2017 ADA Position Statement on Diabetic Neuropathy, has served as member of the ADA Professional Practice Committee, as Chair of the ADA Scientific Research Review Clinical, Chair of the ADA Diabetes & Cardiovascular Disease Interest Group, member of the NEURODIAB Executive Committee, and chairs the DCCT/EDIC Research Review Committee and the Precision Prognostic in Type 1 Diabetes Working Group of the ADA/EASD. She is the 2022 President Elect for Medicine and Science of the American Diabetes Association.

Read More